US Patent Issued to The Trustees of the University of Pennsylvania, The Wistar Institute of Anatomy and Biology on Aug. 4 for "Optimized synthetic consensus immunogenic compositions targeting fibroblast activation protein" (Pennsylvania Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,298, issued on Aug. 4, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and The Wistar Institute of Anatomy and Biology (Philadelphia).

"Optimized synthetic consensus immunogenic compositions targeting fibroblast activation protein" was invented by David Weiner (Merion, Pa.) and Elizabeth Duperret (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is an immunogenic composition comprising a synthetic consensus FAP antigen. Also disclosed herein is a method of treating or preventing a tumor associated pathology in a subject in need thereof, by administering the immunogenic composition to the subjec...